Just minutes before Utah was set to play Washington State in what promised to be one of the least exciting Pac-12 games of the week, ESPN made things much more interesting by reporting on the reason behind Arizona star Allonzo Trier’s long suspension. A poorly kept secret for months in college basketball circles, Trier’s indefinite suspension was the result of a positive test in September 2016 for a performance-enhancing drug. According to the report, Trier had appealed the suspension and won, but the NCAA would not allow him to play until the drug had completely exited his system. This explains why no one has been able to provide realistic timetables on when the sophomore guard would be back on the court.
This is a compelling story for a myriad of reasons. First, any time one of the most recognizable programs in college basketball is involved in something newsworthy, it is going to draw interest. Second, there just aren’t many historical instances where a college basketball player has been suspended for PED use. A quick Google search turns up a number of stories on college football players getting suspended for PED use, but there are very few high-profile cases of PED use in college basketball. Finally, what makes this story so fascinating is the way it has been handled from the very beginning.